1222115

Hikma Pharmaceuticals USA Inc. — FEI 2220525

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 3, 2023
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Cherry Hill, NJ (United States)